CTKB Q2 2025 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$46M-2.2% YoY

Gross Profit

$24M52.3% margin

Operating Income

-$11M-23.3% margin

Net Income

-$6M-12.2% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+10.0%

Cash Flow

Operating Cash Flow

$108,000

Free Cash Flow

-$1M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$493M

Total Liabilities

$116M

Stockholders' Equity

$378M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46M	$47M	-2.2%
Gross Profit	$24M	$25M	-6.2%
Operating Income	-$11M	-$9M	-24.6%
Net Income	-$6M	-$10M	+46.5%

Revenue Segments

Service

$44M58%

Product

$31M42%

Geographic Segments

UNITED STATES

$24M52%

EMEA

$12M27%

Asia Pacific

$8M17%

Other

$2M3%